Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Inflammatory Bowel Diseases

  Free Subscription


16.09.2019

2 Aliment Pharmacol Ther
1 Am J Gastroenterol
1 Clin Gastroenterol Hepatol
2 Dig Dis Sci
4 Eur J Gastroenterol Hepatol
1 Gastroenterol Hepatol
17 Inflamm Bowel Dis
1 J Clin Gastroenterol
4 J Crohns Colitis
1 J Pediatr
2 Lancet Gastroenterol Hepatol
1 Scand J Gastroenterol
2 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. ASHTON JJ, Latham K, Beattie RM, Ennis S, et al
    Review article: the genetics of the human leucocyte antigen region in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2019 Sep 13. doi: 10.1111/apt.15485.
    PubMed     Text format     Abstract available

  2. IANNONE A, Ruospo M, Palmer SC, Principi M, et al
    Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2019 Sep 9. doi: 10.1111/apt.15493.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  3. COHEN ER, Salem M, Ha C
    Managing Immunosuppressed Patients With Inflammatory Bowel Disease During a Measles Outbreak.
    Am J Gastroenterol. 2019 Sep 6. doi: 10.14309/ajg.0000000000000396.
    PubMed     Text format    


    Clin Gastroenterol Hepatol

  4. CASAVANT E, Park KT, Elias JE
    Proteomic discovery of stool protein biomarkers for distinguishing pediatric inflammatory bowel disease flares.
    Clin Gastroenterol Hepatol. 2019 Sep 6. pii: S1542-3565(19)30974.
    PubMed     Text format    


    Dig Dis Sci

  5. JANG J, Kwok B, Zhong H, Xia Y, et al
    Alvimopan for the Prevention of Postoperative Ileus in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2019 Sep 14. pii: 10.1007/s10620-019-05839.
    PubMed     Text format     Abstract available

  6. NGUYEN VQ, Sorrentino D
    Diagnostic and Therapeutic Delays in the Management of Postoperative Crohn's Disease.
    Dig Dis Sci. 2019;64:1388-1389.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  7. KOURKOULIS P, Kapizioni C, Michalopoulos G, Andreou NP, et al
    Novel potential biomarkers for the diagnosis and monitoring of patients with ulcerative colitis.
    Eur J Gastroenterol Hepatol. 2019;31:1173-1183.
    PubMed     Text format     Abstract available

  8. GROCHENIG HP, Waldhor T, Haas T, Wenzl H, et al
    Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2019;31:1211-1219.
    PubMed     Text format     Abstract available

  9. MOSES J, Lambert-Jenkins K, Momotaz H, Sattar A, et al
    Time to antibody detection and associated factors for presence of anti-drug antibodies in pediatric inflammatory bowel disease patients treated with anti-TNF therapy.
    Eur J Gastroenterol Hepatol. 2019;31:1228-1233.
    PubMed     Text format     Abstract available

  10. FEUERSTEIN JD, Curran T, Alvares D, Alosilla M, et al
    Surgery for ulcerative colitis in geriatric patients is safe with similar risk to younger patients.
    Eur J Gastroenterol Hepatol. 2019 Sep 11. doi: 10.1097/MEG.0000000000001529.
    PubMed     Text format     Abstract available


    Gastroenterol Hepatol

  11. RIOS LEON R, Jaureguizar Oriol A, Lopez-Sanroman A, Jimenez Castro D, et al
    Acute severe pulmonary toxicity due to biosimilar infliximab in a Crohn's disease patient.
    Gastroenterol Hepatol. 2019;42:104-105.
    PubMed     Text format    


    Inflamm Bowel Dis

  12. EROS A, Soos A, Hegyi P, Szakacs Z, et al
    Spotlight on Transition in Patients With Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554155. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. TORABI M, Bernstein CN, Yu BN, Wickramasinghe L, et al
    Geographical Variation and Factors Associated With Inflammatory Bowel Disease in a Central Canadian Province.
    Inflamm Bowel Dis. 2019 Aug 23. pii: 5554123. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. ROSEIRA J, Magro F, Fernandes S, Simoes C, et al
    Sexual Quality of Life in Inflammatory Bowel Disease: A Multicenter, National-Level Study.
    Inflamm Bowel Dis. 2019 Aug 27. pii: 5555468. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. KAIMAKLIOTIS P, Ramadugu A, Kang J, Trivedi I, et al
    Comment on: "Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol".
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554376. doi: 10.1093.
    PubMed     Text format    

  16. YE Y, Manne S, Treem WR, Bennett D, et al
    Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016.
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554163. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. FONDELL AW, Mosha MH, Frank CR, Brangi JM, et al
    Health Care Cost for Children Newly Diagnosed With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554164. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. ZHUANG X, Li T, Li M, Huang S, et al
    Systematic Review and Meta-analysis: Short-Chain Fatty Acid Characterization in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 9. pii: 5566405. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. BIANCONE L, Armuzzi A, Scribano ML, Castiglione F, et al
    Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
    Inflamm Bowel Dis. 2019 Jul 19. pii: 5536256. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. CALDERA F, Hillman L, Saha S, Wald A, et al
    Immunogenicity of High Dose Influenza Vaccine for Patients with Inflammatory Bowel Disease on Anti-TNF Monotherapy: A Randomized Clinical Trial.
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554370. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. LIN Z, Wu H, Fu Y, Dai S, et al
    Application of Herbaceous Medications for Inflammatory Bowel Disease as a Complementary and Alternative Therapy.
    Inflamm Bowel Dis. 2019 Aug 31. pii: 5557802. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. GEORGE J, Singh S, Dulai PS, Ma C, et al
    Corticosteroid-Free Remission vs Overall Remission in Clinical Trials of Moderate-Severe Ulcerative Colitis and Crohn's Disease.
    Inflamm Bowel Dis. 2019 Aug 30. pii: 5556866. doi: 10.1093.
    PubMed     Text format     Abstract available

  23. QIN X
    Impaired Inactivation of Digestive Proteases in Lower Gut Due to Inhibition of Gut Bacteria by Food Additives Such as Saccharin and Sucralose as Main Cause of Inflammatory Bowel Disease: A Two-Decades-Long Hypothesis Warrants Testing.
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554159. doi: 10.1093.
    PubMed     Text format    

  24. GREGORY MH, Ciorba MA, Wiitala WL, Stidham RW, et al
    The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Aug 27. pii: 5555523. doi: 10.1093.
    PubMed     Text format     Abstract available

  25. BARBERIO B, D'Inca R, Facchin S, Dalla Gasperina M, et al
    Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With Infliximab.
    Inflamm Bowel Dis. 2019 Aug 29. pii: 5556462. doi: 10.1093.
    PubMed     Text format     Abstract available

  26. KHALILI H
    The Changing Epidemiology of Inflammatory Bowel Disease: What Goes Up May Come Down.
    Inflamm Bowel Dis. 2019 Aug 23. pii: 5554124. doi: 10.1093.
    PubMed     Text format     Abstract available

  27. KOKLU S, Koklu H
    Rectal Candidiasis Mimicking Ulcerative Colitis in an Immunocompetent Patient.
    Inflamm Bowel Dis. 2019 Aug 29. pii: 5556472. doi: 10.1093.
    PubMed     Text format    

  28. CASANOVA MJ, Chaparro M, Minguez M, Ricart E, et al
    Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.
    Inflamm Bowel Dis. 2019 Aug 29. pii: 5556445. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Clin Gastroenterol

  29. DAI C, Jiang M, Sun MJ
    Oral Nano Vitamin D Supplementation and Disease Activity in Ulcerative Colitis.
    J Clin Gastroenterol. 2019 Sep 12. doi: 10.1097/MCG.0000000000001263.
    PubMed     Text format    


    J Crohns Colitis

  30. ALINAGHI F, Tekin HG, Burisch J, Wu JJ, et al
    Global prevalence and bidirectional association between psoriasis and inflammatory bowel disease - A systematic review and meta-analysis.
    J Crohns Colitis. 2019 Aug 30. pii: 5556860. doi: 10.1093.
    PubMed     Text format     Abstract available

  31. RAKNES G, Simonsen P, Smabrekke L
    Corrigendum: The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study.
    J Crohns Colitis. 2019 Sep 9. pii: 5566443. doi: 10.1093.
    PubMed     Text format    

  32. BUTERA A, Di Paola M, Vitali F, De Nitto D, et al
    IL-13 mRNA tissue content identifies two subsets of adult ulcerative colitis patients with different clinical and mucosa-associated microbiota profiles.
    J Crohns Colitis. 2019 Sep 10. pii: 5566583. doi: 10.1093.
    PubMed     Text format     Abstract available

  33. COHEN RD, Bhayat F, Blake A, Travis S, et al
    The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn's Disease: 4 Years of Global Post-Marketing Data.
    J Crohns Colitis. 2019 Aug 13. pii: 5549489. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Pediatr

  34. CHANDRAKUMAR A, Loeppky R, Deneau M, El-Matary W, et al
    Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase Levels.
    J Pediatr. 2019 Sep 6. pii: S0022-3476(19)30973.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  35. RUEMMELE FM
    Safety of anti-TNF biologics in paediatric inflammatory bowel disease.
    Lancet Gastroenterol Hepatol. 2019 Sep 4. pii: S2468-1253(19)30292.
    PubMed     Text format    

  36. WINTZELL V, Svanstrom H, Melbye M, Jess T, et al
    Use of tumour necrosis factor-alpha inhibitors and the risk of serious infection in paediatric inflammatory bowel disease in Denmark: a nationwide cohort study.
    Lancet Gastroenterol Hepatol. 2019 Sep 4. pii: S2468-1253(19)30266.
    PubMed     Text format     Abstract available


    Scand J Gastroenterol

  37. LUDVIGSSON JF, Andersson M, Bengtsson J, Eberhardson M, et al
    Swedish Inflammatory Bowel Disease Register (SWIBREG) - a nationwide quality register.
    Scand J Gastroenterol. 2019 Sep 9:1-13. doi: 10.1080/00365521.2019.1660799.
    PubMed     Text format     Abstract available


    Z Gastroenterol

  38. KOSCHNY R, Allgauer M, Pfeiffenberger J, Seessle J, et al
    Case report: a rare cause of a hypervascular nodule in a noncirrhotic liver.
    Z Gastroenterol. 2019;57:57-60.
    PubMed     Text format     Abstract available

  39. GEORGIADOU E, Fanter L, Brandes A, Ratsch BA, et al
    Perianal fistulas in adult patients with Crohn's disease in Germany - a retrospective cross-sectional analysis of claims data from German sickness funds.
    Z Gastroenterol. 2019;57:574-583.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: